Search for: "Xanodyne Pharmaceuticals, Inc."
Results 21 - 35
of 35
Sorted by Relevance
|
Sort by Date
30 Nov 2022, 4:01 am
Xanodyne Pharmaceuticals, Inc. manufactured Darvon and Darvocet through 2010. [read post]
30 Nov 2022, 4:01 am
Xanodyne Pharmaceuticals, Inc. manufactured Darvon and Darvocet through 2010. [read post]
30 Nov 2022, 4:01 am
Xanodyne Pharmaceuticals, Inc. manufactured Darvon and Darvocet through 2010. [read post]
29 Nov 2010, 6:48 pm
Xanodyne Pharmaceuticals Inc., which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, voluntarily agreed recently to withdraw the medication from the U.S. market at the request of the FDA. [read post]
29 May 2017, 3:00 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218, 1220 (9th Cir.2014), in which the Ninth Circuit held that CAFA’s mass action provision provided jurisdiction to cases coordinated under California Code of Civil Procedure § 404 “for all purposes,” the Court found that the plaintiffs’ petition in Banh sought coordination for pretrial purposes only. [read post]
27 Aug 2012, 6:02 am
As a result of this further adverse safety data, the manufacturer of these drugs, Xanodyne Pharmaceuticals Inc., agreed to withdraw the medication from the U.S. market at the request of the FDA. [read post]
26 Jan 2012, 6:00 am
As a result of this further adverse safety data, the manufacturer of these drugs, Xanodyne Pharmaceuticals Inc., agreed to withdraw the medication from the U.S. market at the request of the FDA. [read post]
5 Dec 2014, 9:00 am
Xanodyne Pharmaceuticals, Inc., No. 13-56306, 2014 WL 6436154 (9th Cir. [read post]
17 Jan 2017, 3:00 am
Xanodyne Pharm., Inc., 771 F.3d 1218 (9th Cir. 2014), finding that a request for coordination and consolidation for all purposes created federal jurisdiction under the CAFA’s mass action provision, the Sixth Circuit vacated the District Court’s order remanding the action. [read post]
14 Aug 2015, 5:00 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218 (9th Cir. 2014). [read post]
26 Jun 2015, 11:30 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218 (9th Cir. 2014), here. [read post]
31 Dec 2014, 5:00 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218 (9th Cir. 2014) (en banc). [read post]
8 Dec 2017, 3:00 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218, 1223 (9th Cir. 2014) summarily reversed the remand orders not only in cases identified in the coordination petition, but also in all other related cases filed in California, regardless of whether or not the plaintiffs at issue had filed a petition for coordination or add-on petition at the time of removal. [read post]
4 May 2011, 7:52 am
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms Morphine Kadian® Extended Release Capsules Actavis Morphine MS Contin Extended Release Tablets Purdue Pharma … [read post]
25 Jun 2014, 2:00 pm
Xanodyne Pharmaceuticals, Inc. v. [read post]
